Viewpoint - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Viewpoint
123456
Next »

Are We Abandoning IQ and OQ?

November 2, 2009
By:Louis A. Angelucci
Pharmaceutical Technology

New standards may overlook critical qualification needs.

Progress Made on the Path to Biosimilars

October 2, 2009
By:Jim Greenwood
Pharmaceutical Technology

BIO supports recent Congressional action toward a 12-year data exclusivity period for innovators.

A Brave New Path for Pharma

September 2, 2009
By:Anthony Farino
Pharmaceutical Technology

Personalized medicine and integrated healthcare delivery require new business and pricing models. This article contains bonus online-exclusive material.

Pharma-Biotech Partnerships: Lessons for Personalized Medicine

August 2, 2009
By:Nafees N. Malik
Pharmaceutical Technology

Big Pharma entered biotech too late. That same mistake can be avoided in personalized medicine.

Opportunities and Challenges in Pharmaceutical Nanotechnology

July 2, 2009
By:David W. Hobson
Pharmaceutical Technology

While regulators begin to address nano-based drugs, industry should get its risk data ready.

Mapping Opportunities for Patent Positions

June 2, 2009
By:Frances Weber, Scott D. Locke
Pharmaceutical Technology

Follow-on biologics could unleash the potential of several industries and may even spark economic recovery.

Industry Leaders Debate Follow-on Biologics Pathway

May 2, 2009
By:Jim Greenwood, Kathleen Jaeger
Pharmaceutical Technology

The organizations' presidents discuss market exclusivity, approval processes, and pending legislation.

Automation Vendor or Partner?

April 2, 2009
By:Bob Lenich, Joanne Salazar
Pharmaceutical Technology

The role of automation suppliers is transforming to meet the pharma industry's demand for change.

Changes to Vial Labels May Affect Patient Safety

March 2, 2009
By:Frederick J. Balboni, Jr.
Pharmaceutical Technology

USP's revised chapter on injectables could harm anticounterfeiting efforts and drug administration.

123456
Next »

ADVERTISEMENT

LCGC E-mail Newsletters
Subscribe:Check the box next to each newsletter you wish to subscribe for:
| Weekly
| Monthly
| Monthly | Weekly
 Name:
 E-mail:

Survey
At this month's AAPS Annual Meeting & Exposition, several graduate students were awarded as young innovators. What are your thoughts on innovation and the next generation?
We need more young innovators and more students enrolling in pharma science programs
Our industry has just the right mix of young and old to keep innovation going
Age is irrelevant when it comes to innovation
We need more young innovators and more students enrolling in pharma science programs
25%
Our industry has just the right mix of young and old to keep innovation going
16%
Age is irrelevant when it comes to innovation
59%
View Results
Jim MillerOutsourcing OutlookJim Miller Facing Reality
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advancing Chiral Chemistry in API Synthesis
Faiz kermaniSpotlightFaiz Kermani Demographic time bomb
FindPharma Custom Search
Featured Jobs

More Jobs

Click here